This phase 2 study will evaluate the efficacy, safety and tolerability of IW-3300, a novel, investigational foam option designed to treat bladder pain associated with interstitial cystitis / bladder pain syndrome (IC/BPS). Researchers believe the investigational treatment may stimulate cells in the abdominopelvic region, which may offer relief from pain associated with IC/BPS.